Advertisement

Topics

I-Therapeutix, Inc. Company Profile

16:45 EDT 22nd June 2018 | BioPortfolio


News Articles [27 Associated News Articles listed on BioPortfolio]

Quotidian Technical Highlights on Selected Biotech Stocks -- Ocular Therapeutix, Onconova ...

www.wallstequities.com/registration Ocular Therapeutix On Monday, shares in Bedford, Massachusettsheadquartered Ocular Therapeutix Inc. recorded a trading volume of 158,186 shares. The stock ended...

Ocular Therapeutix To Present at the H.C. Wainwright Annual Global Life Sciences Conference in Monte Carlo, Monaco on April 8-10, 2018

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, ...

VIDEO: New Ocular Therapeutix CEO highlights opportunities for 2018

WAILEA, Hawaii — At Hawaiian Eye 2018, Antony Mattessich, president and CEO of Ocular Therapeutix, discusses the company’s plans moving forward into 2018. 

Ocular Therapeutix nets $30.6mm via FOPO

Ocular Therapeutix Inc. (developed the first-of-its-kind ReSure sealant for sealing clear corneal incisions following cataract surgery) netted $30.55mm through the follow-on public sale of 6.5mm commo...

Ocular Therapeutix nets $35.1mm via FOPO

Ocular Therapeutix Inc. (developed the first-of-its-kind ReSure sealant for sealing clear corneal incisions following cataract surgery) netted $35.1mm through the follow-on public sale of 7.5mm common...

Ocular Therapeutix announces public stock offering

Ocular Therapeutix announced an underwritten public offering of 6.5 million shares of its common stock, priced at $5 per share, according to a press release.The underwriter of the offering will be gra...

Ocular Therapeutix™ to Present at the 2018 JMP Securities Life Sciences Conference

Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development and commercialization of innovative therapies for diseases and condition...

Ocular Therapeutix™ to Present at the Cowen and Company 38th Annual Health Care Conference

Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditi...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [5 Associated Companies listed on BioPortfolio]

Ocular Therapeutix, Inc. 

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of t...

Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc. is a privately held company based in Bedford, MA, focused on the development and commercialization of ophthalmic therapeutic products using its proprietar...

Ora, Inc.

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye using its p...

Ocular Therapeutix™, Inc.

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the ...

I-Therapeutix, Inc.

More Information about "I-Therapeutix, Inc." on BioPortfolio

We have published hundreds of I-Therapeutix, Inc. news stories on BioPortfolio along with dozens of I-Therapeutix, Inc. Clinical Trials and PubMed Articles about I-Therapeutix, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of I-Therapeutix, Inc. Companies in our database. You can also find out about relevant I-Therapeutix, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record